62 related articles for article (PubMed ID: 37531818)
1. Novel quinoxaline-based VEGFR-2 inhibitors to halt angiogenesis.
Ismail MMF; Shawer TZ; Ibrahim RS; Allam RM; Ammar YA
Bioorg Chem; 2023 Oct; 139():106735. PubMed ID: 37531818
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel nicotinic acid derivatives of potential antioxidant and anticancer activity.
El-Dash Y; Khalil NA; Ahmed EM; Hassanin SO; Gowifel AMH; Hassan MSA
Arch Pharm (Weinheim); 2023 Dec; 356(12):e2300250. PubMed ID: 37792247
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and antitumor screening of new thiazole, thiazolopyrimidine, and thiazolotriazine derivatives as potent inhibitors of VEGFR-2.
Abd Elhameed AA; Ali AR; Ghabbour HA; Bayomi SM; El-Gohary NS
Drug Dev Res; 2023 Dec; 84(8):1664-1698. PubMed ID: 37661648
[TBL] [Abstract][Full Text] [Related]
4. Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-
Alsaif NA; Taghour MS; Alanazi MM; Obaidullah AJ; Al-Mehizia AA; Alanazi MM; Aldawas S; Elwan A; Elkady H
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1093-1114. PubMed ID: 34056992
[TBL] [Abstract][Full Text] [Related]
5. Challenging the anticolorectal cancer capacity of quinoxaline-based scaffold via triazole ligation unveiled new efficient dual VEGFR-2/MAO-B inhibitors.
Ayoup MS; Ammar A; Abdel-Hamid H; Amer A; Abu-Serie MM; Nasr SA; Ghareeb DA; Teleb M; Tageldin GN
Bioorg Chem; 2024 Feb; 143():107102. PubMed ID: 38211551
[TBL] [Abstract][Full Text] [Related]
6. Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and
Alanazi MM; Alaa E; Alsaif NA; Obaidullah AJ; Alkahtani HM; Al-Mehizia AA; Alsubaie SM; Taghour MS; Eissa IH
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1732-1750. PubMed ID: 34325596
[TBL] [Abstract][Full Text] [Related]
7. Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2:
Dahab MA; Mahdy HA; Elkady H; Taghour MS; Elwan A; Elkady MA; Elsakka EGE; Elkaeed EB; Alsfouk AA; Ibrahim IM; Metwaly AM; Eissa IH
J Biomol Struct Dyn; 2024 May; 42(8):4214-4233. PubMed ID: 37261471
[TBL] [Abstract][Full Text] [Related]
8. New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and
Elkady H; Elwan A; El-Mahdy HA; Doghish AS; Ismail A; Taghour MS; Elkaeed EB; Eissa IH; Dahab MA; Mahdy HA; Khalifa MM
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):397-410. PubMed ID: 34961427
[TBL] [Abstract][Full Text] [Related]
9. Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative, docking and MD simulation studies.
Taghour MS; Elkady H; Eldehna WM; El-Deeb N; Kenawy AM; Abd El-Wahab AE; Elkaeed EB; Alsfouk BA; Metwaly AM; Eissa IH
J Biomol Struct Dyn; 2023; 41(21):11535-11550. PubMed ID: 36617888
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers.
Alanazi MM; Eissa IH; Alsaif NA; Obaidullah AJ; Alanazi WA; Alasmari AF; Albassam H; Elkady H; Elwan A
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1760-1782. PubMed ID: 34340610
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative and Antiangiogenic Properties of New VEGFR-2-targeting 2-thioxobenzo[
Abuelizz HA; Marzouk M; Bakheit AH; Awad HM; Soltan MM; Naglah AM; Al-Salahi R
Molecules; 2020 Dec; 25(24):. PubMed ID: 33333992
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and screening of ortho-amino thiophene carboxamide derivatives on hepatocellular carcinomaas VEGFR-2Inhibitors.
AbdElhameid MK; Labib MB; Negmeldin AT; Al-Shorbagy M; Mohammed MR
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1472-1493. PubMed ID: 30191744
[TBL] [Abstract][Full Text] [Related]
13. New benzimidazole-oxadiazole derivatives as potent VEGFR-2 inhibitors: Synthesis, anticancer evaluation, and docking study.
Acar Çevik U; Celik I; Görgülü Ş; Şahin Inan ZD; Bostancı HE; Özkay Y; Kaplacıklı ZA
Drug Dev Res; 2024 Jun; 85(4):e22218. PubMed ID: 38825827
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers.
Kassab AE; Gedawy EM; Hamed MIA; Doghish AS; Hassan RA
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):922-939. PubMed ID: 33896327
[TBL] [Abstract][Full Text] [Related]
15. Novel quinoxaline-3-propanamides as VGFR-2 inhibitors and apoptosis inducers.
Ismail MMF; Shawer TZ; Ibrahim RS; Abusaif MS; Kamal MM; Allam RM; Ammar YA
RSC Adv; 2023 Oct; 13(45):31908-31924. PubMed ID: 37915441
[TBL] [Abstract][Full Text] [Related]
16. Phthalazone tethered 1,2,3-triazole conjugates: In silico molecular docking studies, synthesis, in vitro antiproliferative, and kinase inhibitory activities.
Abdelgawad MA; Bukhari SNA; Musa A; Elmowafy M; Nayl AA; El-Ghorab AH; Sadek Abdel-Bakky M; Omar HA; Hadal Alotaibi N; Hassan HM; Ghoneim MM; Bakr RB
Bioorg Chem; 2023 Apr; 133():106404. PubMed ID: 36812829
[TBL] [Abstract][Full Text] [Related]
17. New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies.
Elkady H; Abuelkhir AA; Rashed M; Taghour MS; Dahab MA; Mahdy HA; Elwan A; Al-Ghulikah HA; Elkaeed EB; Ibrahim IM; Husein DZ; Metwaly A; Eissa IH
Comput Biol Chem; 2023 Dec; 107():107958. PubMed ID: 37714080
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, docking study, and antitumor evaluation of benzamides and oxadiazole derivatives of 3-phenoxybenzoic acid as VEGFR-2 inhibitors.
Heriz MH; Mahmood AAR; Yasin SR; Saleh KM; AlSakhen MF; Kanaan SI; Himsawi N; Saleh AM; Tahtamouni LH
Drug Dev Res; 2024 May; 85(3):e22186. PubMed ID: 38643351
[TBL] [Abstract][Full Text] [Related]
19. Exploring the anticancer properties of a new nicotinamide analogue: Investigations into in silico analysis, antiproliferative effects, selectivity, VEGFR-2 inhibition, apoptosis induction, and migration suppression.
Eissa IH; Yousef RG; Sami M; Elkaeed EB; Alsfouk BA; Ibrahim IM; Husein DZ; Elkady H; Metwaly AM
Pathol Res Pract; 2023 Dec; 252():154924. PubMed ID: 37956639
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and anticancer evaluation of N-sulfonylpiperidines as potential VEGFR-2 inhibitors, apoptotic inducers.
Elgammal WE; Halawa AH; Eissa IH; Elkady H; Metwaly AM; Hassan SM; El-Agrody AM
Bioorg Chem; 2024 Apr; 145():107157. PubMed ID: 38340473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
